http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02185-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1988-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be72c03587fd20b00dfa5374dbb00ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_130d1db94d6d56ada7eb6fcaa4b51e75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b572d50017076e67225e02d5fbbc84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ab92d1d4472529b9e4f8bf9610b6a76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601bc654dec6833738611fba9a8e2c79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96533b248a8f9275eff85c94f6024971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9355c2f0c8585b297ce1cee929590697
publicationDate 1990-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02185-A
titleOfInvention Bisphosphonic acid derivative and medicine thereof
abstract NEW MATERIAL:A compound expressed by formula I [R 1 represents H, alkyl, cycloalkyl, phenyl, (phenyl-substituted) alkenyl or (lower alkoxy-substituted) phenyl lower alkyl; R 2 represents H or lower alkanoyl; R 3 to R 6 represent H or alkyl, provided that at least one of R 2 to R 6 represents group other than H when R 1 represents methyl, ethyl, isopropyl or t-butyl]. n EXAMPLE: Tetraethyl [(5-methyl-3-isoxazolyl)amino]methylene bis(phosphonate). n USE: A bone resorption inhibitor and anti-anthritis agent. n PREPARATION: A 3-amino-isoxazole expressed by formulae II or III, a lower alkyl orthoformate expressed by formula IV and a phosphorous acid ester expressed by formulae V or VI are subjected to reaction preferably at 150°C for 10-60min. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5280022-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001158736-A
priorityDate 1987-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227472854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID405383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415958069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406963788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414778338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15052485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1810216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 35.